Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
14.59
-0.20 (-1.35%)
At close: Sep 4, 2026, 4:00 PM EDT
13.21
-1.38 (-9.46%)
After-hours: Sep 4, 2026, 7:53 PM EDT
Silence Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Silence Therapeutics stock has a consensus rating of "Buy" and an average price target of $33. The average 1-year stock price forecast is 126.18% higher than the current stock price, while the lowest is $10 (-31.46%) and the highest is $75 (+414.05%).
Price Target: $33 (+126.18%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Silence Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $75 | Buy | Reiterates | $75 | +414.05% | Aug 14, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $25 → $32 | Buy | Reiterates | $25 → $32 | +119.33% | Aug 11, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 10, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $4 | Sell | Maintains | $4 | -72.58% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
433.93K
from 559.00K
Decreased by -22.37%
Revenue Next Year
1.00M
from 433.93K
Increased by 131.12%
EPS This Year
-0.36
EPS Next Year
-0.38
from -0.36
EPS and Forward PE are based on non-GAAP adjusted numbers.